Biohaven Ltd logo

Biohaven Ltd

BHVN
Healthcare|Biotechnology|USA
$15.55
-1.24 (-7.39%)
Tangible Book
$0.73

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ null, 23.44, 93.17, 288.29, 791.71 ], "ebit_estimate": [ -478.29, -445.12, -358.44, -311.25, 36.68 ], "ebitda_estimate": [ -429.76, -406.26, -436.55, -497.65, -161.3 ], "net_income_estimate": [ -452.15, -421.47, -391.03, -309.43, 29.27 ], "per_share_eps_estimate": [ -3.09, -2.5, -1.89, -1.37, 0.36 ], "eps_nri_estimate": [ -3.03, -2.4, -1.95, -1.44, 0.28 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ -0.03, -0.18, -0.07, 0.51, 0.79 ], "pretax_income_estimate": [ -451.96, -421.47, -353.77, -309.43, 38.37 ], "operating_cash_flow_per_share_estimate": [ -2.4, -1.59, -1.65, -1.89, -0.45 ], "roa_estimate": [ -116.3, -146.35, -148.65, -76.7, -7 ], "roe_estimate": [ -400.97, -482.71, -389.41, -15.2, -79.1 ], "gross_margin_estimate": [ 85.5, 83.2, 88.33, 83.6, 85.9 ], "operating_cash_flow_estimate": [ -354.28, -234.71, -243.93, -278.25, -65.69 ], "pettm_estimate": [ 0, 0, 0, 0, 42.72 ], "long_term_growth_rate_mean": 32.95, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 33.74, "future_eps_nri_estimate_growth": 32.95, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": 20.14, "future_ebitda_estimate_growth": 14.67, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 17.79, "future_pretax_income_estimate_growth": 20.17, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": 33.66 }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ 0.49, 0.74, 0.98, null, null, 7.75, 13.08, null ], "ebit_estimate": [ -114.74, -113.98, -110.94, -117.78, -118.72, -114.9, -111.22, null ], "ebitda_estimate": [ -103.73, -104.08, -97.71, null, null, null, null, null ], "net_income_estimate": [ -112.35, -111.09, -107.16, -115.52, -116.66, -112.87, -108.71, null ], "per_share_eps_estimate": [ -0.77, -0.72, -0.67, -0.7, -0.7, -0.69, -0.68, null ], "eps_nri_estimate": [ -0.73, -0.68, -0.63, -0.68, -0.69, -0.65, -0.62, -0.81 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -111.72, -110.69, -106.41, -115.48, -116.62, -112.83, -108.83, null ], "operating_cash_flow_per_share_estimate": [ -0.59, -0.52, -0.26, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ -388.5, -177.36, -98.83, null, null, null, null, null ], "gross_margin_estimate": [ null, null, 221, null, null, null, null, null ], "operating_cash_flow_estimate": [ -87.58, -77.25, -38.38, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null, null ], "long_term_growth_rate_mean": 32.95, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 33.74, "future_eps_nri_estimate_growth": 32.95, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": 20.14, "future_ebitda_estimate_growth": 14.67, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 17.79, "future_pretax_income_estimate_growth": 20.17, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": 33.66 }

News

2026-07-09 22:00:02
2026-07-09 21:28:08
2026-06-30 12:01:30
2026-06-30 11:50:25
2026-06-29 14:26:30
2026-06-29 12:30:26
2026-06-29 12:00:08
2026-06-29 11:50:24
2026-06-26 14:30:16